TARA

NASDAQ · Biotechnology

Protara Therapeutic Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.12

+0.02 (+0.49%)

As of Aug 8, 10:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +468.9% upside

Low Target $15.10

Average Target $23.44

High Target $28.04

Current Price $4.12

Current
$4.12

Target
$23.44

$15.10 $23.44 avg $28.04

Scenario Analysis

Bear Case

$15.10

266.5%

Low target

Base Case

$23.44

+468.9%

Avg target

Bull Case

$28.04

+580.6%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$7.82

-47.3% from high

52-Week Low

$2.97

+38.7% from low

Target vs 52W High

$23.44

+199.7% vs high

Next Earnings Report

Aug 10, 2026

Today

EPS Est: $-0.33

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%